Drug Type miRNA, AAV based gene therapy |
Synonyms- |
Target |
Action inhibitors |
Mechanism α-synuclein inhibitors(Synuclein alpha inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Synucleinopathies | Preclinical | United States | 07 May 2024 |





